DE602008000680D1 - Inhibitor der TGF-beta-Aktivierungsreaktion - Google Patents

Inhibitor der TGF-beta-Aktivierungsreaktion

Info

Publication number
DE602008000680D1
DE602008000680D1 DE602008000680T DE602008000680T DE602008000680D1 DE 602008000680 D1 DE602008000680 D1 DE 602008000680D1 DE 602008000680 T DE602008000680 T DE 602008000680T DE 602008000680 T DE602008000680 T DE 602008000680T DE 602008000680 D1 DE602008000680 D1 DE 602008000680D1
Authority
DE
Germany
Prior art keywords
tgf
inhibitor
activation reaction
beta activation
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008000680T
Other languages
English (en)
Inventor
Souichi Kojima
Ryutaro Teraoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Publication of DE602008000680D1 publication Critical patent/DE602008000680D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE602008000680T 2007-03-08 2008-03-10 Inhibitor der TGF-beta-Aktivierungsreaktion Active DE602008000680D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007058222 2007-03-08

Publications (1)

Publication Number Publication Date
DE602008000680D1 true DE602008000680D1 (de) 2010-04-08

Family

ID=39409543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008000680T Active DE602008000680D1 (de) 2007-03-08 2008-03-10 Inhibitor der TGF-beta-Aktivierungsreaktion

Country Status (5)

Country Link
US (1) US7732401B2 (de)
EP (1) EP1967526B1 (de)
JP (1) JP2008247900A (de)
CN (1) CN101525373A (de)
DE (1) DE602008000680D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803553B2 (en) * 2003-09-04 2010-09-28 Riken Methods of use of antibodies which recognize a protease cleavage site of an LAP fragment of TGF-β
WO2011102483A1 (ja) * 2010-02-19 2011-08-25 独立行政法人理化学研究所 ヒトTGF-βのLAPに結合する抗体
MX2015014704A (es) * 2013-05-10 2017-02-28 Southern Res Inst Compuestos, composiciones y métodos para el tratamiento de las enfermedades a través de la inhibición de la actividad del tgf-b.
US20170073406A1 (en) * 2014-05-06 2017-03-16 Scholar Rock, Inc. Compositions and methods for growth factor modulation
WO2016105365A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
CN107530423B (zh) 2015-01-14 2022-04-05 布里格姆及妇女医院股份有限公司 用抗lap单克隆抗体治疗癌症
WO2019075090A1 (en) 2017-10-10 2019-04-18 Tilos Therapeutics, Inc. ANTI-LAP ANTIBODIES AND USES THEREOF
US11046729B2 (en) * 2017-10-26 2021-06-29 Southern Research Institute Dipeptide analogs as TGF-beta inhibitors
US11130802B2 (en) 2018-10-10 2021-09-28 Tilos Therapeutics, Inc. Anti-lap antibody variants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6860171B1 (en) * 1999-12-29 2005-03-01 Shimano, Inc. Drive mechanism for a bicycle transmission assist mechanism
JP2003252792A (ja) 2002-03-04 2003-09-10 Inst Of Physical & Chemical Res 肝再生促進剤
JP2004121001A (ja) 2002-08-07 2004-04-22 Japan Tobacco Inc ＴＧＦ−βＩＩ型受容体に対する高親和性モノクローナル抗体
FR2857305B1 (fr) * 2003-07-10 2005-10-07 Faurecia Sieges Automobile Siege de vehicule automobile a dossier articule comportant des moyens de blocage du dossier en cas de choc frontal
US7803553B2 (en) 2003-09-04 2010-09-28 Riken Methods of use of antibodies which recognize a protease cleavage site of an LAP fragment of TGF-β
WO2005039570A1 (ja) 2003-10-28 2005-05-06 Riken ＴＧＦ－β情報伝達経路阻害剤
JP2005239695A (ja) 2004-02-27 2005-09-08 Mitsui Chemicals Inc ＴＧＦ−β産生抑制ペプチド
ITMI20040812A1 (it) * 2004-04-26 2004-07-26 Chemi Spa Processo per la formazione di legami disofluro in peptidi ciclici
EP2012814B1 (de) * 2006-04-12 2013-05-22 Genzyme Corporation Verfahren zur behandlung von autoimmunerkrankungen

Also Published As

Publication number Publication date
CN101525373A (zh) 2009-09-09
EP1967526A1 (de) 2008-09-10
EP1967526B1 (de) 2010-02-24
US7732401B2 (en) 2010-06-08
JP2008247900A (ja) 2008-10-16
US20080280827A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
CY2020024I2 (el) Αναστολεiς βητα-λακταμασων
CY2017016I2 (el) Αναστολεις πρωτεασωματος
SMT201600267B (it) Inibitori di syk imidazopirazinici
DE602008000680D1 (de) Inhibitor der TGF-beta-Aktivierungsreaktion
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
DK2271642T3 (da) Pyridylinhibitorer af hedgehog signalering
BRPI0814797A2 (pt) Inibidores dna-pk
FI20075600A0 (fi) Komponentin eliniän määritys
BR112012002134A2 (pt) compostos inibidores de apaf-1
DK3208269T3 (da) Inhibitorer af c-fms-kinase
BRPI0920608A2 (pt) compostos quimicos
BRPI0922880A2 (pt) compostos inibidores de quinase
BRPI0918564A2 (pt) inibidores
BRPI0820677A2 (pt) Misturas de compostos pesticidas
BR112012001070A2 (pt) inibidores de ativação de complementos
BRPI0912152A2 (pt) umbilical
DE102009028879A8 (de) Wasserbasierter 2-Komponenten Klebstoff
EP2184608A4 (de) Nichtspezifischer reaktionshemmer
BRPI0821567A2 (pt) Misturas de compostos pesticidas
BRPI0820650A2 (pt) Misturas de compostos pesticidas
DK2173197T3 (da) Fremgangsmåde
BRPI0906577A2 (pt) compostos químicos
ATE522533T1 (de) Pyrazolopyrimidinonkinaseinhibitor
FR2938461B1 (fr) Marteau anti-vibration
FI20075320A0 (fi) Uusia käyttökelpoisia inhibiittoreita

Legal Events

Date Code Title Description
8364 No opposition during term of opposition